结缔组织病相关性间质性肺病的肺移植治疗现状
Updates in lung transplantation for connective tissue disease-associated interstitial lung disease
刘虎 1贺瑞卿 1谢敏2
作者信息
- 1. 山西白求恩医院(山西医学科学院)同济山西医院呼吸与危重症医学科,山西太原 030032
- 2. 华中科技大学同济医学院附属同济医院呼吸与危重症医学科,湖北武汉 430030
- 折叠
摘要
肺移植是终末期肺病的重要救治手段,目前间质性肺疾病(ILD)接受肺移植的患者日益增多,但其中主要以特发性间质性肺炎为主,而结缔组织病相关间质性肺病(CTD-ILD)亦有大量终末期肺病患者,虽有肺移植的指征,但由于多器官受累,围手术期管理复杂,一直是肺移植领域的难点之一.本文总结了近年来CTD-ILD的肺移植相关治疗进展,以期对受体选择和围手术期管理等临床问题提供相关资料.
Abstract
Lung transplantation has become a crucial treatment option for patients with end-stage lung disease.In recent years,the number of patients with interstitial lung disease(ILD)undergoing lung transplantation has been steadily increasing,with the majority of these cases involving idiopathic interstitial pneumonia.However,connective tissue disease-related interstitial lung disease(CTD-ILD)also presents a significant number of patients with end-stage lung disease who meet the criteria for lung transplantation.Despite this,due to the involvement of multiple organs and the complexity of perio-perative management,CTD-ILD remains one of the major challenges in the field of lung transplantation.This article reviews recent advancements in lung transplantation for CTD-ILD,aiming to provide relevant information on recipient selection and perioperative management for clinicians.
关键词
结缔组织病/间质性肺病/肺移植Key words
Connective tissue disease/Interstitial lung disease/Lung transplantation引用本文复制引用
出版年
2024
NETL
NSTL
万方数据